Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 23;27(9):110678.
doi: 10.1016/j.isci.2024.110678. eCollection 2024 Sep 20.

Mapping structural distribution and gating-property impacts of disease-associated mutations in voltage-gated sodium channels

Affiliations

Mapping structural distribution and gating-property impacts of disease-associated mutations in voltage-gated sodium channels

Amin Akbari Ahangar et al. iScience. .

Abstract

Thousands of voltage-gated sodium (Nav) channel variants contribute to a variety of disorders, including epilepsy, cardiac arrhythmia, and pain disorders. Yet, the effects of more variants remain unclear. The conventional gain-of-function (GoF) or loss-of-function (LoF) classifications are frequently employed to interpret mutations' effects and guide therapy for sodium channelopathies. Our study challenges this binary classification by analyzing 525 mutations associated with 34 diseases across 366 electrophysiology studies, revealing that diseases with similar GoF/LoF effects can stem from unique molecular mechanisms. Utilizing UniProt data, we mapped over 2,400 disease-associated missense mutations across Nav channels. This analysis pinpoints key mutation hotspots and maps patterns of gating-property impacts for the mutations, respectively, located around the selectivity filter, activation gate, fast inactivation region, and voltage-sensing domains. This study shows great potential to enhance prediction accuracy for mutational effects based on the structural context, paving the way for targeted drug design in precision medicine.

Keywords: genetics; molecular biology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

None
Graphical abstract
Figure 1
Figure 1
The gating properties and functional transitions of Nav channels (A) Gating properties are listed with their GoFGP (green) or LoFGP (red) effects. These properties comprised maximal current amplitude (Imax), half-activation voltage in steady-state activation (V1/2 Act), half-inactivation voltage in steady-state fast inactivation (V1/2 Inact), recovery rate (τrec), persistent current (IP), and gating pore current (or ω current, Iω). (B) The gating properties with their relevant transitions in the functional cycle of Nav channels. The Nav structure has four similar subunits (I to IV), and each subunit comprises six transmembrane helices (S1-S6). The first four TMs (S1 to S4) form a voltage-sensing domain (VSD), and the TMs S5 and S6 contribute to the pore domain (PD). Sensing the membrane depolarization, VSDs undergo resting-to-activated structural transition. Then the channel inactivates mediated by allosteric blocking of IFMT motif when depolarization is prolonged to a certain timescale. Thirdly, the repolarization of membrane potential allows recovery from the fast inactivation to the resting state. The gating properties are labeled with their relevant functional step. Please check the supplementary materials for a colorblind-friendly version of this figure.
Figure 2
Figure 2
The workflow in the study for collecting electrophysiology and genetic data (A) The workflow to search and extract electrophysiology research articles that study the mutational effects on gating properties. A total of 854 articles from Scopus were reviewed, and a rigorous selection process identified 366 articles relevant to this study. From these articles, 525 unique mutations with gating properties were identified and selected as the core data for further analysis and investigations. (B) Data extraction steps to retrieve disease and variant data from UniProt. Initially, more than 36 million mutations in UniProt were filtered, resulting in a refined dataset of 2.4K non-cancerous pathogenic missense mutations in Nav.
Figure 3
Figure 3
The classification of Nav associated diseases based on overall mutational effect or impacts on gating properties (A) 34 sodium channelopathies are grouped based on a binary GOFo/LOFo classification according to previous literature (Table S2). Diseases are colored in green for GoFo phenotypes, red for LoFo phenotypes, and yellow for diseases with mixed overall effect (MIXo). (B) Gating-property impacts of 536 mutations are mapped into their associated 34 diseases. The diseases are also clustered based on the similarity of the gating-property impacts of their associated mutations. The GoFGP/LoFGP preference index is depicted colorimetrically with dark green representing highly consistent GoFGP effect, dark red for highly consistent LoFGP effect, and black no such a gating-property data available. The percentage (%) of mutations affecting a certain gating property within a specific phenotype is shown in each grid. Please check the supplementary materials for a colorblind-friendly version of this figure.
Figure 4
Figure 4
Preferences of gating-property impacts for disease-associated mutations in different structural segments The variant effects on six gating properties of 525 mutations from 366 papers are mapped into seven major structural segments (A), different selections in VSDs (B), and PD (C). HS stands for the mutation hotspots of corresponding structural segments. The percentage (%) of mutations affecting a certain gating property within a specific structural segment is shown in each grid. GoFGP/LoFGP preference index is depicted colorimetrically with dark green representing highly consistent GoFGP effect, dark red for highly consistent LoFGP effect, and black for no such gating-property data available. (D) Shows the selection for selectivity filter (SF), activation gate (AG), fast inactivation region (FIR), as well as the upper and lower part for PD and VSD. The disease-associated mutations are represented in blue (upper) and red (lower) spheres. Please check the supplementary materials for a colorblind-friendly version of this figure.
Figure 5
Figure 5
Mapping the mutation hotspots in Nav channels The annotated disease-associated mutations from UniProt are mapped to equivalent positions of MSA of the 9 human Nav channels and the linear protein structure of the channel. The number of phenotypes (upper panel), the number of mutations (middle panel), and the number of proteins with mutation at the same position (lower panel) are used to determine the mutation hotspots. The data for pathogenic missense mutations are shown in blue bars and all information related to all missense (including pathogenic, benign, and uncertain) variants are shown in orange. Hotspots in the N terminal, C terminal, intracellular, and extracellular loops of the proteins are shown in this figure with residue IDs from Nav1.5.
Figure 6
Figure 6
The mutation hotspots in VSDs (A–D) The hotspots showing in the MSA of Nav channels for 4 VSDs. All mutation hotspots in VSDs are labeled with the residue IDs in Nav1.5. (E–H) Mapping the hotspots in the structure of VSDs. Residues are shown in licorice and colored according to Taylor color scheme.
Figure 7
Figure 7
The mutation hotspots in the pore domain (A–D) The hotspots in PD showing in the MSA of Nav channels. (E–G) Mapping of the hotspots in the PD of the Nav1.5 structure from the sideview (E) and bottom view (F). The mutation hotspots at the intracellular loops are shown in the right bottom image (G).
Figure 8
Figure 8
Mapping the phenotypes based on the gating-property impacts of associated mutations Phenotype clustering of missense mutation in Nav based on the similarity of gating-property impacts. Black cells represent no data for the corresponding disease segment. The heatmap is colored based on the percentage (%) of mutations affecting a certain gating property within a specific phenotype. Diseases are colored in green (GoFo), red (LoFo), yellow (MiXo), and black for undetermined phenotypes. Please check the supplementary materials for a colorblind-friendly version of this figure.

Update of

References

    1. Alexander S.P.H., Mathie A.A., Peters J.A., Veale E.L., Striessnig J., Kelly E., Armstrong J.F., Faccenda E., Harding S.D., Davies J.A., et al. The Concise Guide to PHARMACOLOGY 2023/24: Ion channels. Br. J. Pharmacol. 2023;180:S145–S222. doi: 10.1111/BPH.16178. - DOI - PMC - PubMed
    1. Mantegazza M., Cestèle S., Catterall W.A. Sodium Channelopathies of Skeletal Muscle and Brain. Physiol. Rev. 2021;101:1633–1689. doi: 10.1152/physrev.00025.2020. - DOI - PMC - PubMed
    1. Pan X., Li Z., Zhou Q., Shen H., Wu K., Huang X., Chen J., Zhang J., Zhu X., Lei J., et al. Structure of the human voltage-gated sodium channel Nav1.4 in complex with beta1. Science. 2018;362 doi: 10.1126/science.aau2486. - DOI - PubMed
    1. Ghovanloo M.R., Aimar K., Ghadiry-Tavi R., Yu A., Ruben P.C. Physiology and Pathophysiology of Sodium Channel Inactivation. Curr. Top. Membr. 2016;78:479–509. doi: 10.1016/bs.ctm.2016.04.001. - DOI - PubMed
    1. George A.L. Inherited disorders of voltage-gated sodium channels. J. Clin. Invest. 2005;115:1990–1999. doi: 10.1172/JCI25505. - DOI - PMC - PubMed

LinkOut - more resources